Evidence map›Paper›PMID 37642997›Full record

ArticleThe Journal of experimental medicine2023

Diphtheria toxin activates ribotoxic stress and NLRP1 inflammasome-driven pyroptosis.

Kim Samirah Robinson, Gee Ann Toh, Muhammad Jasrie Firdaus, Khek Chian Tham, Pritisha Rozario, Chrissie K Lim, Ying Xiu Toh, Zhi Heng Lau, Sophie Charlotte Binder, Jacob Mayer and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Lethal toxin-equipped effector cells for the potential treatment of cancer.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Review
  10. Redefining Shiga toxin-induced human cell death as NLRP1- and gasdermin E-mediated pyroptosis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Secondary Necrosis Following Caspase-Activation can Occur Independently of Gasdermin E.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Kim Samirah Robinson *Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID 0000-0003-1182-8789
Gee Ann Toh *Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID 0000-0002-7417-8376
Muhammad Jasrie FirdausLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID 0000-0003-4843-9605
Khek Chian ThamThe A*STAR Skin Research Labs , Singapore, Singapore.ORCID 0000-0002-5702-2986
Pritisha RozarioLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID 0000-0001-7718-044X
Chrissie K LimInstitute of Molecular and Cell Biology , Agency for Science, Technology and Research, Singapore, Singapore.ORCID 0000-0002-1011-5720
Ying Xiu TohThe A*STAR Skin Research Labs , Singapore, Singapore.ORCID 0000-0002-5643-1921
Zhi Heng LauThe A*STAR Skin Research Labs , Singapore, Singapore.ORCID 0009-0009-1753-6681
Sophie Charlotte BinderInstitute of Innate Immunity, Medical Faculty, University of Bonn , Bonn, Germany.ORCID 0009-0004-5573-1131
Jacob MayerInstitute of Innate Immunity, Medical Faculty, University of Bonn , Bonn, Germany.ORCID 0000-0003-2598-7326
Carine BonnardThe A*STAR Skin Research Labs , Singapore, Singapore.ORCID 0000-0003-1922-017X
Florian I SchmidtInstitute of Innate Immunity, Medical Faculty, University of Bonn , Bonn, Germany.ORCID 0000-0002-9979-9769
John E A CommonThe A*STAR Skin Research Labs , Singapore, Singapore.ORCID 0000-0002-3280-7365
Franklin L ZhongLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID 0000-0002-0516-6021
Agency for Science, Technology and Research · SGNanyang Technological University · SGUniversity of Bonn · DENational Skin Centre · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ZAKα-driven ribotoxic stress response (RSR) is activated by ribosome stalling and/or collisions. Recent work demonstrates that RSR also plays a role in innate immunity by activating the human NLRP1 inflammasome. Here, we report that ZAKα and NLRP1 sense bacterial exotoxins that target ribosome elongation factors. One such toxin, diphtheria toxin (DT), the causative agent for human diphtheria, triggers RSR-dependent inflammasome activation in primary human keratinocytes. This process requires iron-mediated DT production in the bacteria, as well as diphthamide synthesis and ZAKα/p38-driven NLRP1 phosphorylation in host cells. NLRP1 deletion abrogates IL-1β and IL-18 secretion by DT-intoxicated keratinocytes, while ZAKα deletion or inhibition additionally limits both pyroptotic and inflammasome-independent non-pyroptotic cell death. Consequently, pharmacologic inhibition of ZAKα is more effective than caspase-1 inhibition at protecting the epidermal barrier in a 3D skin model of cutaneous diphtheria. In summary, these findings implicate ZAKα-driven RSR and the NLRP1 inflammasome in antibacterial immunity and might explain certain aspects of diphtheria pathogenesis.

Indexed as

DiphtheriaDiphtheria ToxinHumansImmunity, InnateInflammasomesNLR ProteinsPyroptosisDiphtheria ToxinInflammasomesNLRP1 protein, humanNLR Proteins

Identifiers

PMID37642997
PMCPMC10465786
OpenAlexW4386241570

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.